Table 2 The numbers of susceptible and resistant isolates in the training and validation dataset and clinical breakpoints for 24 drugs.

256

215

41

(−1, 8, 8, 8, 8)

65

54

11

(−1, 8, 8, 8, 8)

32

167

135

32

(0, 8, 8, 8, 8)

42

33

9

(0, 8, 8, 8, 8)

32

146

21

125

(1, 1, 1.5, 2, 8)

37

5

32

(1, 1, 2, 3, 8)

32

167

42

125

(−3, −3, −2,1, 6)

42

10

32

(−3, −3, −2, 1.25, 6)

4

146

46

100

(1, 2, 3, 6, 8)

37

11

26

(−3, 2, 3, 7, 8)

32

167

27

140

(−1, −1, 0, 1, 8)

42

7

35

(−1, 0, 0, 1, 8)

16

256

23

233

(−1, 0, 0, 1,8)

65

6

59

(−1, 0, 1, 1, 8)

32

167

27

140

(−3, −3, −3, −2, 6)

42

6

36

(−3, −3, −2, −1.75, 4)

4

256

178

78

(1, 3, 8, 8, 8)

65

45

20

(1, 4, 8, 8, 8)

32

256

27

229

(−7, −5, −3, −2, 4)

65

7

58

(−7, −3, −2, −1, 6)

1

256

44

212

(−3, −3, −1, 1, 3)

65

12

53

(−3, − 3, − 1, 1, 6)

4

256

2

254

(−1, −1, −1, −1, 5)

65

1

64

(−1, −1, −1, 0, 7)

32

146

14

132

(−3, −3, −3, −3, 6)

37

3

34

(−3, −3, −3, −3, 6)

2

256

161

95

(1, 3, 6, 8, 8)

65

41

24

(1, 3, 7, 8, 8)

32

256

34

222

(−1, −1, −1, 1, 8)

65

9

56

(−1, −1, −1, 1, 8)

16

256

73

183

(0, 1, 2, 8, 8)

65

19

46

(0, 1, 2, 8, 8)

64

167

1

166

(−3, −3, −3, −3, 6)

42

0

42

(−3, −3, −3, −3, −2)

4

256

102

154

(1, 2, 4, 8, 8)

65

26

39

(1, 2, 4, 8, 8)

32

256

215

41

(0, 7, 8, 8, 8)

65

54

11

(0, 7, 8, 8, 8)

32

167

122

45

(1, 4, 5, 8, 8)

42

30

12

(1, 4.75, 5, 8, 8)

32

167

119

48

(5, 7, 10, 10, 12)

42

29

13

(3, 9.75, 10, 10, 10)

512

167

135

32

(−1, 6, 7, 8, 8)

42

34

8

(−1, 6, 7, 8, 8)

16

167

0

167

(−3, −3, −2, −1, 0)

42

0

42

(−3, −2, −2, −1, −1)

4

167

115

52

(−1, −1, 8, 8, 8)

42

29

13

(−1, 6.25, 8, 8, 8)

16